Sartorius Extends PAT Portfolio

Sartorius Stedim Biotech (SSB) has entered into a global development agreement with em-tec, a company that specializes in non-invasive flow engineering solutions for biopharma processes for accurate measurement of flow rates and mass balances. In particular, this technology is used in downstream processes, such as virus inactivation, as well as in ultrafiltration and diafiltration.
 
Em-tec will employ its technology to jointly develop single-use components, such as FlowTube. Sartorius will exclusively market these applications and distribute them under the brand name of BioPAT Flow.
 
The new BioPAT Flow expands SSB’s process analytics portfolio in the area of sensor technology, allowing precise, reproducible data to be collected on flow rates and mass balances without coming in contact with the medium during measurement.
 
“The sensors make our downstream unit operations even more intelligent, significantly increasing the level of automation. Integrated into our system solutions, these sensors are powerful tools for designing robust biopharmaceutical processes and further optimizing them,” said Stefan Schlack, senior vice president of marketing at SSB.
 
Dr. Hannspeter Schubert, managing director of em-tec, said, “Sartorius Stedim Biotech is among the top global suppliers in automated bioprocess solutions and has a strong globally based sales and marketing network. We are pleased that Sartorius has opted for our basic technology of non-invasive flow rate measurement. The use of our sensors in fully integrated, automated bioprocesses represents an ideal application field and an innovative technological advance for us.”